Investment Banking Analyst 2/3 (Life Sciences/Biopharma) Middle Market

Our client, a presigious middle market investment bank, is actively seeking an Analyst 2/3 for their life-sciences team in NYC. This brand name investment bank offers a key role within an experienced team. No H1Bs, Stem-OPTs or other visas at this time. RIFs ok.

The successful candidate will support senior bankers in executing M&A and financing transactions across the life sciences sub-sector. This position provides direct exposure to CEO, CFO, and Board level contacts, along with significant responsibility and advancement opportunities.

Ideal candidates will have previous healthcare M&A investment banking experience at the Analyst level.

Primary Responsibilities:

• Participate in client transactions, projects, and assignments
• Interact with clients, internal banking teams, and product teams
• Assist in preparing presentations and marketing materials (e.g., CIM, Management Presentations)
• Conduct valuation analyses and financial modeling of clients and targets
• Review business plans, conduct research, and analyze financial statements
• Manage due diligence processes, including virtual data room preparation and counterparty Q&A

Required Qualifications:

• 1+ years of investment banking experience, preferably in healthcare-M&A related transactions
• Strong financial modeling and analytical skills, including knowledge of financial accounting
• BS or BA in finance or similar field with an exemplary academic record
• Outstanding written and oral communication skills
• High motivation, energy, and interpersonal skills
• Ability to manage multiple tasks in a dynamic, meritocratic, team-oriented environment
• Proficiency in Microsoft Office

This role offers an excellent opportunity for a driven professional to advance their career in healthcare investment banking within a prestigious middle market firm.